Close

Analyst Ratings for NLS Pharmaceutics (NLSP)

NLSP Rating Summary

  |   Expand Research on NLSP
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/14/2023 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 0.82
(0.13)		 -84.15% Details
9/6/2022 Laidlaw Yale Jen New Coverage Buy
(N/A)		 6.00
(N/A)		 0.51
(0.13)		 -74.51% Details